GLP1R and obesity due to melanocortin 4 receptor deficiency: Precision nutrition may therefore represent a viable alternative to pharmacologic strategies, particularly given the high costs and adherence challenges associated with anti-obesity medications such as GLP-1 receptor agonists [7].